# Commission Regulation (EC) No 508/1999 of 4 March 1999 amending Annexes I to IV to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, Division 2.3.1

Extent: E+W+S+N.I.

Avermectins
Phramacologically active substance(s)
Marker residue
Animal species
MRLs
Target tissues
Other provisions
Abamectin
Avermectin B1a
Bovine
10 μg/kg
Fat
20 μg/kg
Liver
Doramectin
Doramectin
Bovine
10 μg/kg
Muscle
Not for use in bovine from which milk is produced for human consumption
150 μg/kg
Fat
100 μg/kg
Liver
30 μg/kg
Kidney
Porcine, ovine
20 μg/kg
Muscle
Not for use in ovine from which milk is produced for human consumption
100 μg/kg
Fat
50 μg/kg
Liver
30 μg/kg
Kidney
Eprinomectin
Eprinomectin B1a
Bovine
30 μg/kg
Muscle
30 μg/kg
Fat
600 μg/kg
Liver
100 μg/kg
Kidney
30 μg/kg
Milk
Ivermectin
22, 23-Dihydro-avermectin B1a
Bovine
40 μg/kg
Fat
100 μg/kg
Liver
Porcine, ovine, equidae
20 μg/kg
Fat
15 μg/kg
Liver
Deer, including reindeer
20 μg/kg
Muscle
100 μg/kg
Fat
50 μg/kg
Liver
20 μg/kg
Kidney
Moxidectin
Moxidectin
Bovine, ovine
50 μg/kg
Muscle
500 μg/kg
Fat
100 μg/kg
Liver
50 μg/kg
Kidney

---
Source: https://www.legislation.gov.uk/eur/1999/508/annex/I/division/2/division/2.3/division/2.3.1 (the official version)
Page: https://openlegislation.uk/eu-regulation-1999-508/annex-I/division-2/division-2.3/division-2.3.1
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.